Stay updated with breaking news from Michael Guy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Canalevia®-CA1 is currently FDA conditionally approved for treatment of CID in dogs and is the first and only treatment for CID in dogs to receive any type of approval from
Dog Study Published in PLOS ONE Shows Statistically Significant Results ...
This study, conducted by Jaguar family company Napo Pharmaceuticals in collaboration with Puma Biotechnology, is one of three important studies providing scientific rationale for the use of crofelemer for prevention
FDA Approves Renewal of Canalevia-CA1, Jaguar Health’s Drug for Chemotherapy-Induced ...
04.12.2023 - Canalevia-CA1 is the first and only treatment for chemotherapy-induced diarrhea (CID) in dogs to receive any type of approval from the FDACrofelemer, Jaguar's novel, oral plant-based drug sustainably harvested from the Croton lechleri tree, is the ... Seite 1